1Department of Anesthesiology, Chung Shan Medical University Hospital, Taichung, Taiwan
Outline
Musculoskeletal diseases are common causes of chronic pain, they severely impair the patients’ quality of life. An aging population could lead to enormously large number of patients diagnosed with musculoskeletal diseases. Management of musculoskeletal diseases can be surgical or non-surgical. Surgical modalities include tissue repair, a joint replacement surgery, and so forth. With the rising cost surgical procedures, the financial burden of health care may be growing, and the quality of life among general populations will be affected eventually.
Dextrose Prolotherapy is another cost-effective treatment option. Avoiding surgical intervention and with lower cost, some cases reported clinically significant improvement with dextrose Prolotherapy. However, the actual mechanism of
dextrose Prolotherapy is yet not totally clear. Most investigators proposed that by injection at least 10% dextrose into tendon or ligament insertions, inflammatory process will be induced, proliferation of various cells at injection site will be noted and finally healing of the injured structures will take place.Some other investigators found that dextrose injections below a 10% solution directly stimulate proliferation of cells and tissue without causing a histological inflammatory reaction. Both mechanisms mentioned above could reduce the pain severity and improve the daily activity and quality.
This review focus on dextrose Prolotherapy on some common painful musculoskeletal diseases, the research evidence, and its possible explanations.
Prolotherapy; Glucose;Musculoskeletal diseases; Chronic pain
References
Lawrence RC, Felson DT, Helmick CG, et al.
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II.
Arthritis Rheum. 2008;58(1):26-35. doi:10.1002/ art.23176
Barbour KE, Helmick CG, Theis KA, Murphy LB, Hootman JM, and Brady TJ
Prevalence of doctor- diagnosed arthritis and arthritis-attributable activity limitation-United States, 2003-2005.
Morbility and Mortality Weekly Report. 2006;55:1089-1092.
Kurtz S, Ong K, Lau E, Mowat F, and Halpern M
Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030.
J Bone Joint Surg Am. 2007;89(4):780-785. doi:10.2106/JBJS.F.00222
Hackett G
Ligament and Tendon Relaxation Treated by Prolotjerapy.
Third Edition. Springfield IL: Charles C. Thomas, 1958.
Hauser R, Baird N, Cukla J
A retrospective observational study on Hackett-Hemwall dextrose Prolotherapy for unresolved hand and finger pain at an outpatient charity clinic in rural Illinois.
Journal of Prolotherapy. 2010;2(4)480-485
Hauser R, et al.
Prolo Your Pain Away! Second Edition.
Beulah Land Press, Oak Park IL. 2004, Ch22
Latalski M, Walczyk A, Fatyga M, et al.
Allergic reaction to platelet-rich plasma (PRP): Case report.
Medicine (Baltimore). 2019;98(10):e14702.
Distel LM and Best TM
Prolotherapy: a clinical review of its role in treating chronic musculoskeletal pain.
PM & R : J Inj Funct Rehabil. 2011; 3: S78-S81
Fullerton BD, Reeves KD
Ultrasonography in regenerative injection (Prolotherapy) using dextrose, platelet-rich plasma, and other injectants.
Phys Med Rehabil Clin N Am 2010; 21: 585–605. doi: 10.1016/j.pmr.2010.06.003
Steilen D, Hauser R, Woldin B, Sawyer S
Chronic Neck Pain: Making the Connection Between Capsular Ligament Laxity and Cervical Instability.
The Open Orthopaedics Journal. 2014;8:326–345.
Anderson JM
Exploiting the inflammatory response on biomaterials research and development..
J Mater Sci Mater Med. 2015 Mar;26(3):121. doi: 10.1007/ s10856-015-5423-5
Kim HJ, Jeoung TS, Kim WS, and Park YS
Comparison of histological changes in accordance with the level of dextrose-concentration in experimental Prolotherapy model.
Journal of Korean Academy of Rehabilitation Medicine. 2003;27:935-940.
Wu TJ, Fong YC, Lin CY, Huang YL, and Tang CH
Glucose enhances aggrecan expression in chondrocytes via the PKCalpha/p38-miR141-3p signaling pathway.
Journal of Cellular Physiology, 233, 6878–6887.
Ross A. Hauser, MD, Marion A. Hauser, MS, RD, Nicole M. Baird, CHFP
Evidence-Based Use of Dextrose Prolotherapy for Musculoskeletal Pain: A Scientific Literature Review.
Journal of Prolotherapy. 2011;3(4):765-789.
Reeves K, et al.
Evidence-based regenerative injection therapy (prolotherapy) in sports medicine
In Seidenberg P, Beutler A (eds.) The Sports Medicine Resource Manual. 2008; Saunders Publishing, Philadelphia PA, Chapter 50
Natarajan R, Gonzales N, Xu L, and Nadler JL
Vascular smooth muscle cells exhibit increased growth in response to elevated glucose.
Biochem Biophys Res Commun. 1992 Aug 31;187(1):552- 60.
McGinn S, Poronnik P, King M, Gallery ED, and Pollock CA
High glucose and endothelial cell growth: novel effects independent of autocrine TGF-beta 1 and hyperosmolarity.
Am J Physiol Cell Physiol. 2003 Jun;284(6):C1374-86.
Maniquis-Smigel L, Dean Reeves K, Jeffrey Rosen H, Lyftogt J, Graham-Coleman C, Cheng AL, and Rabago D
Short Term Analgesic Effects of 5% Dextrose Epidural Injections for Chronic Low Back Pain: A Randomized Controlled Trial.
Anesth Pain Med. 2016 Dec 6;7(1):e42550.
İlker Solmaz, Serkan Akpancar, Aydan Örsçelik, Özlem Yener-Karasimav & Deniz Gül
Dextrose injections for failed back surgery syndrome: a consecutive case series.
Eur Spine J. 2019;28(7):1610-1617. doi:10.1007/s00586-019-06011-3
S.Cömert Kiliç, M.Güngörmüş
Is dextrose Prolotherapy superior to placebo for the treatment of temporomandibular joint hypermobility? A randomized clinical trial.
Int J Oral Maxillofac Surg. 2016;45:813-819.
Nagori SA, Jose A, Gopalakrishnan V, Roy ID, Chattopadhyay PK, Roychoudhury A
The efficacy of dextrose Prolotherapy over placebo for temporomandibular joint hypermobility: a systematic review and meta-analysis.
J Oral Rehabil. 2018;45:998–1006.
Refai H, Altahhan O, Elsharkawy R
The efficacy of dextrose Prolotherapy for temporomandibular joint hypermobility: a preliminary prospective, randomized, double-blind, placebo-controlled clinical trial.
J Oral Maxillofac Surg. 2011;69:2962-2970.
Mustafa, R, Güngörmüş, M, Mollaoğlu, N
Evaluation of the efficacy of different concentrations of dextrose Prolotherapy in temporomandibular joint hypermobility treatment.
J Craniofac Surg. 2018;29:e461-e465.
W.F. Louw, K.D. Reeves, S.K. Lam, A.L. Cheng, D. Rabago
Treatment of Temporomandibular Dysfunction With Hypertonic Dextrose Injection (Prolotherapy): A Randomized Controlled Trial With Long-term Partial Crossover
Mayo Clin Proc, 94 (5) (2019), pp. 820-832.
Rabago D, Lee KS, Ryan M, Ryan M, Chourasia AO, Sesto ME, Zgierska A, Kijowski R, Grettie J, Wilson J, and Miller D
Hypertonic dextrose and morrhuate sodium injections (Prolotherapy) for lateral epicondylosis (Tennis Elbow).
Am J Phys Med Rehabil. 2013;92(7):587–596.
Hauser RA, Lackner JB, Steilen-Matias D, and Harris DK
A Systematic Review of Dextrose Prolotherapy for Chronic Musculoskeletal Pain.
Clin Med Insights Arthritis Musculoskelet Disord. 2016; 9: 139–159.
Rabago D, Nourani B
Prolotherapy for Osteoarthritis and Tendinopathy: a Descriptive Review.
Curr Rheumatol Rep. 2017;19(6):34. doi:10.1007/s11926-017-0659-3
Rabago D, Patterson JJ, Mundt M, Kijowski R, Grettie J, Segal NA, and Zgierska A
Dextrose Prolotherapy for knee osteoarthritis: a randomized controlled trial.
Ann Fam Med. 2013;11(3):229–37.
Krstičević M, Jerić M, Došenović S, Jeličić Kadić A and Puljak L
Proliferative injection therapy for osteoarthritis: a systematic review.
Int Orthop. 2017;41(4):671-679. doi:10.1007/s00264-017- 3422-5
Arias-Vázquez PI, Tovilla-Zárate CA, Legorreta- Ramírez BG, Fonz WB, Magaña-Ricardez D, González-CastroTB, Juárez-Rojop IE, and NarváezLL
Prolotherapy for knee osteoarthritis using hypertonic dextrose vs other interventional treatments: systematic review of clinical trials.
Adv Rheumatol. 2019;59(1):39. Published 2019 Aug 19. doi:10.1186/s42358-019-0083-7
Kim WM, Lee HG, Jeong CW, Kim CM, and Yoon MH
A randomized controlled trial of intra- articular Prolotherapy versus steroid injection for sacroiliac joint pain.
J Altern Complement Med. 2010;16(12):1285–90.
Kim HS, Jung KH, Park IH, Ryu JW, Sun KJ, Lim KJ, and Jo DH
Diagnosis and treatment of sacral asymlocation in back pain patients.
Korean J Pain. 2007;20:130–7.
Hooper RA, Yelland M, Fonstad P, and Southern D
Prospective case series of litigants and non- litigants with chronic spinal pain treated with dextrose Prolotherapy.
Int Musculoskeletal Med. 2011;33(1):15–20.
Dagenais S, Yelland MJ, Del Mar C, and Schoene ML
Prolotherapy injections for chronic low- back pain.
Cochrane Database Syst Rev. April 18, 2007;2:CD004059.
Kim MY, Na YM, and Moon JH
Comparison on treatment effects of dextrose water, saline, and lidocaine for trigger point injections.
J Korean Acad Rehabil Med. 1997;21:967–73.